Keyphrases
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
28%
Between-host
14%
Clinical Trials
14%
Cross-linker
14%
Cytomegalovirus
42%
Cytomegalovirus Disease
14%
Cytomegalovirus Infection
100%
Cytomegalovirus Reactivation
28%
Donor Cells
28%
Donor-specific Tolerance
14%
First-in-man
14%
Gene Transcription
14%
Graft Outcome
14%
Host Cell
14%
Human Cytomegalovirus
14%
Human Primates
14%
Immediate-early Gene
14%
Immunosuppression
28%
Induced Tolerance
14%
Infection Tolerance
100%
Inflammation
14%
Multiple Sclerosis
14%
Murine Model
14%
Murine Studies
14%
Organ Donor
14%
Pretransplant
14%
Receptor Tyrosine Kinase
28%
Recipient Outcomes
14%
Seropositivity
14%
Tolerance Induction
28%
Tolerance Strategy
14%
Tolerogenic
14%
Transplantation Tolerance
100%
Xenogeneic
14%
Medicine and Dentistry
1 (3 Dimethylaminopropyl) 3 Ethylcarbodiimide
25%
Clinical Trial
12%
Cytomegalovirus
62%
Cytomegalovirus Infection
100%
Genetic Transcription
12%
Host Cell
12%
Immediate Early Gene
12%
Immunosuppressive Treatment
25%
Multiple Sclerosis
12%
Murine Cytomegalovirus
12%
Organ Donor
12%
Protein Tyrosine Kinase
25%
Transplantation
62%
Transplantation Tolerance
100%
Immunology and Microbiology
Cytomegalovirus
85%
Cytomegalovirus Infection
100%
Genetic Transcription
14%
Host Cell
14%
Immediate Early Gene
14%
Immunosuppression
28%
Multiple Sclerosis
14%
Murine Cytomegalovirus
14%
Myeloid
14%
Seropositivity
14%
Transplantation Tolerance
100%